This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Valeant Pharmaceuticals International Inc (VRX)

NYSE: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents n.a. 322.60M 600.34M 916.09M
Receivables n.a. 2.08B 1.81B 913.84M
Inventories n.a. 950.60M 882.97M 531.26M
Other Current Assets n.a. 8.90M 15.94M 90.98M
Total Current Assets n.a. 4.19B 3.89B 2.78B
Property, Plant & Equipment, Gross n.a. 2.29B 2.07B 636.23M
Accumulated Depreciation & Depletion n.a. 977.90M 838.84M 173.51M
Property, Plant & Equipment, Net n.a. 1.31B 1.23B 462.72M
Intangibles 0.00 11.26B 12.85B 9.31B
Other Non-Current Assets 0.00 193.10M 195.47M 183.75M
Total Non-Current Assets 0.00 22.16B 24.08B 15.17B
Liabilities & Shareholder Equity
Total Assets 0.00 26.35B 27.97B 17.95B
Accounts Payable n.a. 398.00M 326.97M 227.38M
Short Term Debt 0.00 7.10M 204.76M 480.18M
Other Current Liabilities n.a. 559.00M 114.46M 19.91M
Total Current Liabilities n.a. 2.73B 2.51B 1.82B
Long Term Debt 0.00 15.25B 17.16B 10.54B
Deferred Income Taxes n.a. 2.33B 2.32B 1.35B
Other Non-Current Liabilities n.a. 603.90M 742.93M 522.82M
Minority Interest 3.90M -1.30M 2.47M 0.00
Total Non-Current Liabilities 0.00 18.31B 20.34B 12.41B
Total Liabilities 0.00 21.04B 22.85B 14.23B
Preferred Stock Equity n.a. 0.00 0.00 0.00
Common Stock Equity 0.00 5.31B 5.12B 3.72B
Common Par n.a. 0.00 0.00 0.00
Additional Paid In Capital 0.00 8.59B 8.53B 6.21B
Cumulative Translation Adjustment n.a. 0.00 0.00 0.00
Retained Earnings 0.00 -2.37B -3.28B -2.37B
Treasury Stock n.a. 0.00 0.00 0.00
Other Equity Adjustments n.a. -915.90M -132.78M -119.40M
Total Capitalization n.a. 20.57B 22.28B 14.25B
Total Equity 0.00 5.31B 5.12B 3.72B
Total Liabilities & Stock Equity 0.00 26.35B 27.97B 17.95B
Total Common Shares Outstanding 343.10M 334.40M 333.04M 303.86M
Preferred Shares n.a. 0.00 0.00 0.00
Treasury Shares n.a. 0.00 0.00 0.00
Basic Weighted Shares Outstanding 341.82M 335.40M 321.00M 305.45M
Diluted Weighted Shares Outstanding 346.62M 341.50M 321.00M 305.45M
Number of Employees NA 16800 17200 7000
Number of Part-Time Employees NA 0 0 0
VRX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

VRX Valeant Pharmaceuticals International Inc

Chart of VRX

Analysts Ratings for VRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 9 8
Moderate Buy 0 0 0 1
Hold 8 8 5 5
Moderate Sell 0 0 0 0
Strong Sell 3 3 1 0
GET VRX ANALYST REPORT

VRX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs